NASDAQ : MDLN
Medline Inc. — Key statistics
Healthcare · Medical Instruments & Supplies · United States
Last price 32 USD (Oct 29, 2026, 4:00 PM EDT) · Market cap 42.07B
Overview · Financial statements · Key statistics · Dividends · Company profile · Price history · Reports
Key statistics
Valuation
| Measure | Value |
|---|
| Market Cap | 42.23B |
| Enterprise Value | 52.17B |
Dates
| Measure | Value |
|---|
| Earnings Date | Nov 4, 2026 |
| Ex-Dividend Date | n/a |
Shares
| Measure | Value |
|---|
| Current Share Class | 877.35M |
| Shares Outstanding | 1.31B |
| Shares Change (YoY) | -94.99% |
| Shares Change (QoQ) | +4.37% |
| Owned by Insiders (%) | 1.11% |
| Owned by Institutions (%) | 61.24% |
| Float | 369.50M |
Ratios
| Measure | Value |
|---|
| PE Ratio | 40.37 |
| Forward PE | 20.96 |
| PS Ratio | 1.41 |
| Forward PS | 1.31 |
| PB Ratio | 2.43 |
| P/TBV Ratio | n/a |
| P/FCF Ratio | 27.31 |
| P/OCF Ratio | 21.20 |
| PEG Ratio | n/a |
Evratios
| Measure | Value |
|---|
| EV / Earnings | 74.42 |
| EV / Sales | 1.74 |
| EV / EBITDA | 20.72 |
| EV / EBIT | 34.92 |
| EV / FCF | 33.74 |
Financialposition
| Measure | Value |
|---|
| Current Ratio | 4.33 |
| Quick Ratio | 2.45 |
| Debt / Equity | 0.66 |
| Debt / EBITDA | 4.76 |
| Debt / FCF | 8.18 |
| Interest Coverage | 1.91 |
Financialefficiency
| Measure | Value |
|---|
| Return on Equity (ROE) | 4.94% |
| Return on Assets (ROA) | 2.46% |
| Return on Invested Capital (ROIC) | 4.16% |
| Return on Capital Employed (ROCE) | 4.08% |
| Weighted Average Cost of Capital (WACC) | n/a |
| Revenue Per Employee | $665,311 |
| Profits Per Employee | $15,578 |
| Employee Count | 45,000 |
| Asset Turnover | 0.79 |
| Inventory Turnover | 4.81 |
Taxes
| Measure | Value |
|---|
| Income Tax | 197.00M |
| Effective Tax Rate | 18.29% |
Stockprice
| Measure | Value |
|---|
| Beta (5Y) | n/a |
| 52-Week Price Change | n/a |
| 50-Day Moving Average | 34.51 |
| 200-Day Moving Average | 39.65 |
| Relative Strength Index (RSI) | 31.56 |
| Average Volume (20 Days) | 8,656,500 |
Shortselling
| Measure | Value |
|---|
| Short Interest | 40.82M |
| Short Previous Month | 52.69M |
| Short % of Shares Out | 3.10% |
| Short % of Float | 11.05% |
| Short Ratio (days to cover) | 4.51 |
Incomestatement
| Measure | Value |
|---|
| Revenue | 29.94B |
| Gross Profit | 7.51B |
| Operating Income | 1.49B |
| Pretax Income | 1.08B |
| Net Income | 701.00M |
| EBITDA | 2.52B |
| EBIT | 1.49B |
| Earnings Per Share (EPS) | $0.80 |
Balancesheet
| Measure | Value |
|---|
| Cash & Cash Equivalents | 2.70B |
| Total Debt | 12.64B |
| Net Cash | -9.94B |
| Net Cash Per Share | -$7.56 |
| Equity (Book Value) | 19.08B |
| Book Value Per Share | 13.19 |
| Working Capital | 9.03B |
Cashflow
| Measure | Value |
|---|
| Operating Cash Flow | 1.99B |
| Capital Expenditures | -446.00M |
| Depreciation & Amortization | 1.02B |
| Net Borrowing | -4.11B |
| Free Cash Flow | 1.55B |
| FCF Per Share | $1.18 |
Margins
| Measure | Value |
|---|
| Gross Margin | 25.09% |
| Operating Margin | 4.99% |
| Pretax Margin | 3.60% |
| Profit Margin | 2.31% |
| EBITDA Margin | 8.41% |
| EBIT Margin | 4.99% |
| FCF Margin | 5.16% |
Dividends
| Measure | Value |
|---|
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| FCF Payout Ratio | n/a |
| Buyback Yield | 94.99% |
| Shareholder Yield | 94.99% |
| Earnings Yield | 2.48% |
| FCF Yield | 3.66% |
Analystforecasts
| Measure | Value |
|---|
| Price Target | $44.31 |
| Price Target Difference | 37.95% |
| Analyst Consensus | Buy |
| Analyst Count | 27 |
| Revenue Growth Forecast (3Y) | 8.50% |
| EPS Growth Forecast (3Y) | 10.73% |
Stocksplits
| Measure | Value |
|---|
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
| Measure | Value |
|---|
| Altman Z-Score | 2.21 |
| Piotroski F-Score | 6 |
Fairvalue
| Measure | Value |
|---|
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | |
| Graham Upside | |